Christophe Michoud

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Hoffmann-La Roche Inc., Roche Palo Alto LLC, F. Hoffmann-La Roche Ag. Active years: 2000-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christophe Michoud. Retrieved from https://idiyas.com/inventor/christophe-michoud

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 26.7

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.5

ph-index = 4

Forward Citations = 48(Granted Patents)

Company Filing History:

12 out of 5,027

Hoffmann-La Roche Inc.

F. Hoffmann-La Roche Ag

patents

Years Active: 2000-2018

Loading Chart...

Areas of Expertise:

Tetrahydro-benzodiazepinones

Antiproliferative Compounds

Benzotriazole

Thiazole

JNK Modulators

Diacylglycerol

Thiazolyl-benzimidazoles

Pyrimido Compounds

Quinolines

Azolo-oxindoles

Hetero-azepinones

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10053431 - Tetrahydro-benzodiazepinones (2018-08-21),

2. 9611224 - Antiproliferative benzo [B] azepin-2-ones (2017-04-04),

3. 9394263 - Substituted hetero-azepinones (2016-07-19),

4. 8962622 - Benzotriazole kinase modulators (2015-02-24),

5. 8404859 - Thiazole and thiophene compounds (2013-03-26),

6. 8399462 - JNK modulators (2013-03-19),

7. 7504513 - Thiazolyl-benzimidazoles (2009-03-17),

8. 7485752 - Diacylglycerol acyltransferase inhibitors (2009-02-03),

9. 7317125 - Diacylglycerol acyltransferase inhibitors (2008-01-08),

10. 7250515 - Thiazolinone 3,4-disubstituted quinolines (2007-07-31),

11. 7241893 - Thiazolinone 2-substituted quinolines (2007-07-10),

12. 7115740 - Pyrimido compounds having antiproliferative activity (2006-10-03),

13. 7084270 - Pyrimido compounds having antiproliferative activity (2006-08-01),

14. 6221867 - 4,5-pyrazinoxindoles (2001-04-24),

15. 6153634 - 4,5-azolo-oxindoles (2000-11-28),

Title: The Innovative Contributions of Christophe Michoud

Introduction

Christophe Michoud is a prominent inventor based in New York, NY (US), known for his significant contributions to the field of pharmaceuticals. With a total of 15 patents to his name, Michoud has made remarkable strides in developing compounds aimed at treating serious health conditions, particularly cancer.

Latest Patents

Among his latest patents are the Tetrahydro-benzodiazepinones, which disclose compounds of Formula I, or pharmaceutically acceptable salts thereof. These compounds are described in detail within the application, along with methods for their use in cancer treatment. Another notable patent is for Antiproliferative benzo [B] azepin-2-ones, which also outlines compounds of Formula (I) and their potential applications in combating cancer.

Career Highlights

Throughout his career, Michoud has worked with esteemed companies such as Hoffmann-La Roche Inc. and Roche Palo Alto LLC. His work in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.

Collaborations

Some of his notable coworkers include Kin-Chun Thomas Luk and Kenneth Carey Rupert. Their collaboration has likely fostered an environment of creativity and innovation, leading to the development of impactful pharmaceutical solutions.

Conclusion

Christophe Michoud's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations highlight his commitment to advancing medical treatments, particularly in the fight against cancer.

Profile summary based on public USPTO records.